IceCure Medical Ltd (ICCM)

1.0900 +0.0400 (+3.81%) At close: 04:00PM EDT

IceCure Medical Ltd

7 Ha’Eshel Street
PO Box 3163
Caesarea 3079504
Israel
972 4 623 0333
https://www.icecure-medical.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 71

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Eyal Shamir	CEO & Director	416.36k	N/A	1961
Mr. Ronen Tsimerman CPA	CFO & COO	306.4k	N/A	1969
Ms. Tlalit Bussi Tel-Tzure	Vice President of Business Development & Global Marketing	248.44k	N/A	1971
Ms. Merav Nir Dotan	Vice President of Human Resources	197.96k	N/A	1969
Ms. Galit Malik	Vice President of Operations & Service	N/A	N/A	1973

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

Corporate governance

IceCure Medical Ltd’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.